当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 现金流量表

海尔生物

(688139)

  

流通市值:104.16亿  总市值:104.16亿
流通股本:3.18亿   总股本:3.18亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,156,363,413.19553,238,068.822,331,426,426.331,585,401,166.51
  收到的税费返还24,623,824.358,890,451.8936,631,224.7522,367,268.49
  收到其他与经营活动有关的现金18,378,285.0718,575,983.3661,228,597.9346,861,396.45
  经营活动现金流入小计1,199,365,522.61580,704,504.072,429,286,249.011,654,629,831.45
  购买商品、接受劳务支付的现金650,033,142.42265,382,591.231,159,181,659.06840,997,402.69
  支付给职工以及为职工支付的现金333,363,699.84182,109,920.34573,465,500.65419,820,522.81
  支付的各项税费71,377,311.1535,877,317.22140,800,365.81108,520,079.23
  支付其他与经营活动有关的现金108,951,302.4460,115,473.74264,171,805.23171,324,375.38
  经营活动现金流出小计1,163,725,455.85543,485,302.532,137,619,330.751,540,662,380.11
  经营活动产生的现金流量净额35,640,066.7637,219,201.54291,666,918.26113,967,451.34
二、投资活动产生的现金流量:
  收回投资收到的现金2,279,900,0001,102,900,0002,964,720,441.372,032,950,672
  取得投资收益收到的现金13,120,658.216,637,955.2316,107,763.4322,749,755.27
  处置固定资产、无形资产和其他长期资产收回的现金净额90,338.23-819,713.89840,040
  投资活动现金流入小计2,293,110,996.441,109,537,955.232,981,647,918.692,056,540,467.27
  购建固定资产、无形资产和其他长期资产支付的现金68,398,152.1228,103,424.73126,704,812.7887,493,691.77
  投资支付的现金2,175,569,771.63954,000,0003,485,754,0922,265,280,672
  取得子公司及其他营业单位支付的现金47,647,50045,000,000160,405,720.83158,324,843.76
  投资活动现金流出小计2,291,615,423.751,027,103,424.733,772,864,625.612,511,099,207.53
  投资活动产生的现金流量净额1,495,572.6982,434,530.5-791,216,706.92-454,558,740.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金--4,465,172.8550,000
  其中:子公司吸收少数股东投资收到的现金--4,465,172.8550,000
  取得借款收到的现金20,000,00015,000,00010,000,00010,000,000
  收到其他与筹资活动有关的现金358,868,861.1179,362,611.12179,520,750-
  筹资活动现金流入小计378,868,861.1194,362,611.12193,985,922.810,550,000
  偿还债务支付的现金10,000,0005,000,00018,588,206.829,500,000
  分配股利、利润或偿付利息支付的现金148,454,174.72136,486.11163,930,252.88164,576,248.67
  其中:子公司支付给少数股东的股利、利润--840,481.61-
  支付其他与筹资活动有关的现金435,948,901.54207,394,777.29238,294,737.5456,454,457.71
  筹资活动现金流出小计594,403,076.26212,531,263.4420,813,197.24230,530,706.38
  筹资活动产生的现金流量净额-215,534,215.16-18,168,652.28-226,827,274.44-219,980,706.38
四、汇率变动对现金及现金等价物的影响5,555,997.041,204,511.814,434,529.58962,777.38
五、现金及现金等价物净增加额-172,842,578.67102,689,591.57-721,942,533.52-559,609,217.92
  加:期初现金及现金等价物余额534,704,030.68534,704,030.681,256,646,564.21,256,646,564.2
  期末现金及现金等价物余额361,861,452.01637,393,622.25534,704,030.68697,037,346.28
补充资料:
  净利润147,213,041.4-381,008,045.8-
  资产减值准备2,932,521.61-2,756,186.74-
  固定资产和投资性房地产折旧35,622,434.12-70,389,400.37-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧35,238,111.62-69,620,755.37-
    投资性房地产折旧384,322.5-768,645-
  无形资产摊销24,164,032.34-45,738,498.63-
  长期待摊费用摊销1,145,098.75-1,841,795.77-
  递延收益摊销-1,631,822.66--7,696,411.04-
  处置固定资产、无形资产和其他长期资产的损失18,792.77--233,571.76-
  固定资产报废损失171,159.07-1,864,142.84-
  公允价值变动损失-1,894,977.61--5,468,787.54-
  财务费用-13,611,814.62--12,156,302.68-
  投资损失-15,907,644.87--23,794,761.37-
  递延所得税-13,314,357.87--19,479,822.9-
  其中:递延所得税资产减少-10,199,357.76--14,084,705.66-
    递延所得税负债增加-3,115,000.11--5,395,117.24-
  存货的减少29,355,937.96--68,722,067.41-
  经营性应收项目的减少-95,632,254.5--173,735,221.4-
  经营性应付项目的增加-79,564,536.38-76,510,475.64-
  现金的期末余额361,861,452.01-534,704,030.68-
  减:现金的期初余额534,704,030.68-1,256,646,564.2-
  现金及现金等价物的净增加额-172,842,578.67--721,942,533.52-
公告日期2025-08-272025-04-302025-03-292024-10-30
审计意见(境内)标准无保留意见
TOP↑